echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Nutrition News > For the first time, a class of antifibrotic drugs has been found to be effective in the treatment of rheumatoid arthritis

    For the first time, a class of antifibrotic drugs has been found to be effective in the treatment of rheumatoid arthritis

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    For the first time, researchers have found that a class of antifibrotic drugs can slow the progression
    of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA).


    "Interstitial lung disease is a relatively common complication in patients with rheumatoid arthritis that can progress and cause premature death in 10 percent of such patients," said
    Joshua Solomon, M.


    Rheumatoid arthritis (RA) is one of the most common autoimmune diseases in the
    world.


    "With this study, we demonstrate that antifibroid drugs, as a class of drugs, have a reproducible effect in reducing the rate of disease progression when measured by lung capacity," said
    Ivan Rosas, Ph.


    The National Jewish Health Center is the nation's leading respiratory hospital
    .


    essay

    Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.